Perceptions of access to long-acting reversible contraception removal among women in Burkina Faso.


Journal

Contraception
ISSN: 1879-0518
Titre abrégé: Contraception
Pays: United States
ID NLM: 0234361

Informations de publication

Date de publication:
Jan 2024
Historique:
received: 26 06 2023
revised: 29 09 2023
accepted: 02 10 2023
medline: 4 12 2023
pubmed: 7 10 2023
entrez: 6 10 2023
Statut: ppublish

Résumé

Long-acting reversible contraception (LARC) initiation has been well-studied and intervened upon. Because LARC requires provider intervention for initiation and removal, it is critical to measure informed choice at the time of desired discontinuation as well. We examined perceptions of access to LARC discontinuation among women at two sites in Burkina Faso, where LARC is the dominant method in the contraceptive mix. We analyzed data from a 2017-2018 population-based, cross-sectional survey of 281 implant users and 55 intrauterine device users at two sites in Burkina Faso. We measured perceptions of access to LARC discontinuation through survey items assessing whether participants (1) were informed on how to discontinue the method, (2) believed they could have LARC removed without a lot of difficulty, (3) believed cost would be a barrier to discontinuation, (4) had ever attempted to have a provider remove LARC, and (5) successfully had LARC removed. The distribution of these measures was examined in the population and for differences by gravida, parity, domestic partnership, fertility desires, and recency of last childbirth. Thirty-eight (11%) of current LARC users reported that they were not informed on how to discontinue, 56 (17%) believed having their device removed would be difficult, and 54 (16%) believed cost would be a barrier to removal. Of women who attempted removal, providers did not immediately remove LARC on request for 10 (28%). Findings indicate that LARC uptake is an insufficient measure of reproductive access or choice. Future studies should include patient-centered measures that span the full duration of contraceptive use. This paper finds that a sizable proportion of LARC users lack information about method discontinuation and perceive or experience barriers to method removal. These findings call for a reconsideration of free and informed contraceptive choice to include the entire duration of contraceptive use, not only the time of method provision.

Identifiants

pubmed: 37802461
pii: S0010-7824(23)00408-0
doi: 10.1016/j.contraception.2023.110302
pii:
doi:

Substances chimiques

Contraceptive Agents, Female 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

110302

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Auteurs

Natasha A Sokol (NA)

Department of Psychiatry and Human Behavior, Warren Alpert Medical School, Brown University, Providence, Rhode Island, United States; Center for Behavioral and Preventive Medicine, The Miriam Hospital, Providence, Rhode Island, United States. Electronic address: natasha_sokol@brown.edu.

Nathalie Sawadogo (N)

Institut Supérieur des Sciences de la Population, Université Joseph KI-ZERBO, Ouagadougou, Burkina Faso.

Brooke W Bullington (BW)

Department of Epidemiology, University of North Carolina Gillings School of Global Public Health, Chapel Hill, North Carolina, United States; Carolina Population Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States.

Katherine Tumlinson (K)

Carolina Population Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States; Department of Health Policy and Management, University of North Carolina Gillings School of Global Public Health, Chapel Hill, North Carolina, United States.

Ana Langer (A)

Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States.

Abdramane Soura (A)

Institut Supérieur des Sciences de la Population, Université Joseph KI-ZERBO, Ouagadougou, Burkina Faso.

Pascal Zabre (P)

Centre de Recherche en Santé de Nouna, Nouna, Burkina Faso.

Ali Sie (A)

Centre de Recherche en Santé de Nouna, Nouna, Burkina Faso.

Janet A Johnson (JA)

Center for Behavioral and Preventive Medicine, The Miriam Hospital, Providence, Rhode Island, United States.

Leigh Senderowicz (L)

Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States; Department of Gender and Women's Studies, University of Wisconsin-Madison, Madison, Wisconsin, United States; Department of Obstetrics and Gynecology, University of Wisconsin-Madison, Madison, Wisconsin, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH